Guangdong VTR Bio-Tech Co., Ltd was established in 1991, whose headquarter located in Zhuhai City, Guangdong Province, China. Since its establishment, VTR has been focusing on research & development and industrial application of bio-medicine and bio-agriculture & animal husbandry; it has been engaged in three industries of bio-enzyme preparation, steroid hormone API materials and functional feed additives. VTR is one of the first National High-Tech Enterprises, the first listed company in China's bio-enzyme industry, as well as a globally competitive steroid hormone pharmaceutical enterprise.
After years of development, VTR has formed the unique technology advantages of its own on the strength of its strong technology resources. VTR has 1 national technology center, 1 academician workstation, 1 postdoctoral research station and 10 provincial R&D engineering centers. At present, VTR owns 4 proprietary technologies, 174 invention patents, especially in the bioengineering field. This high-tech company owns various kinds of core technologies including genetic engineering technology, bio-fermentation technology, compound enzyme synergy technology, steroid hormone biochemical synthesis technology, medicinal plant extraction technology and other core technologies, which provide a solid foundation for its rapid growth and sustainable development.
After going public, the range of the company’s business has been expanding rapidly and the growth in its performance has been accelerated dramatically based on public financing platform. VTR has gradually developed into a competitive bio-technological company in China, which has 26 holding companies with over 2,500 employees, among them, 300 are R&D employees and 30% of them have master or doctor degrees. There are 15 production bases in Guangdong, Hunan, Henan and Inner Mongolia provinces, and a comprehensive overseas marketing network across more than 60 countries and regions. Meanwhile VTR keeps long-term partnerships with more than 2,300 quality direct sales customers from both home and abroad.
In the future, VTR will adhere to the bioengineering as the main aim, customer value-oriented, bio-medicine and bio-agriculture & animal husbandry based, and will be committed to become a global bio-enzyme preparation benchmark enterprise, the core enterprise of global steroid hormone API materials and China's leading functional feed additives, while working hand in hand with industry customers to innovate modern biotechnology solutions, and achieve the harmonious and healthy development of human and nature.